Benjamin Edwards Inc’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-26
Closed 742
2023
Q4
$0 Buy
26
+23
+767% +$313 ﹤0.01% 658
2023
Q3
$0 Buy
3
+2
+200% +$42 ﹤0.01% 669
2023
Q2
$0 Sell
1
-8
-89% -$174 ﹤0.01% 710
2023
Q1
$0 Sell
9
-16
-64% -$430 ﹤0.01% 743
2022
Q4
$1K Sell
25
-2
-7% -$51 ﹤0.01% 706
2022
Q3
$1K Sell
27
-41
-60% -$1.24K ﹤0.01% 691
2022
Q2
$2K Sell
68
-39
-36% -$1.37K ﹤0.01% 670
2022
Q1
$4K Sell
107
-19
-15% -$650 ﹤0.01% 662
2021
Q4
$4K Buy
126
+101
+404% +$3.29K ﹤0.01% 652
2021
Q3
$1K Buy
+25
New +$800 ﹤0.01% 531

Other funds holding OGN

Benjamin Edwards Inc's OGN Position: Q1 2024 in Review

Benjamin Edwards Inc sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 26 shares.

Benjamin Edwards Inc first reported a position in OGN in Q3 2021 and held it in 10 quarters. The position peaked at $4K in Q1 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Benjamin Edwards Inc reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Benjamin Edwards Inc sold 26 Organon & Co shares in Q1 2024.
  • Benjamin Edwards Inc first reported a position in Organon & Co in Q3 2021 and held it in 10 quarters.
  • Benjamin Edwards Inc's Organon & Co position peaked at $4K in Q1 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Benjamin Edwards Inc's 13F filing for Q1 2024, filed 29 Apr 2024.